Join leading investor and BD voices as they delve into the real risk–reward equation – from funding strategy and scaling RLTs to forging partnerships that accelerate patient access and ROI. Bring your questions and gain true insights into what it really takes to drive growth while mitigating risk in this rapidly evolving space.

• Evaluating economic challenges and opportunities in scaling RLTs from preclinical discovery to commercial launch
• Identifying strategies for securing ongoing investment despite supply chain and regulatory constraints
• Exploring collaborative models with manufacturers, regulators, and advocacy groups to accelerate patient access and return on investment